We represented Healthcare Bluebook in its acquisition of the Quality division of Quantros, Inc., a leading provider of quality analytics software for healthcare providers and payors. Healthcare Bluebook uses industry-leading objective quality and price data and claims-driven ROI reporting to deliver healthcare value insights to consumers, employers, and healthcare providers and payors. Terms of the transaction were not disclosed.
Healthcare Bluebook Acquires Quality Division of Quantros, Inc.
You Also May Be Interested In:
ALS Education’s Charter School Management Business Sold to Satori Capital, Epic Partners Backed Company
Representation of Parthenon Capital, a growth-oriented private equity firm, as healthcare regulatory counsel in its investment in RxSense, a high-growth healthcare technology company that utilizes its proprietary technology platform to provide innovative prescription savings solutions to consumers and pharmacy benefits administration and analytics to enterprise customers
Lead Counsel to POINT Biopharma Inc. in its Proposed SPAC Business Combination with Research Alliance Corp. I
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.